Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL27614157 | 1.00 | ALDH1A1 (0.32) | ALDH1A1SHBGTHRBATML3MBTL1 | |
| SCHEMBL13269215 | 1.00 | ALDH1A1 (0.32) | ALDH1A1SHBGTHRBATML3MBTL1 | |
| SCHEMBL106805 | 1.00 | ALDH1A1 (0.32) | ALDH1A1SHBGTHRBATML3MBTL1 | |
| Water SCHEMBL28105372 | 0.98 | ALDH1A1 (0.32) | ALDH1A1SHBGTHRBATML3MBTL1 | |
| SCHEMBL106690 | 0.97 | — | — | |
| SCHEMBL105968 | 0.92 | — | — | |
| SCHEMBL9422227 | 0.91 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL30576991 | 0.89 | CYP1A2 (0.30) | CYP1A2 | |
| SCHEMBL30576994 | 0.89 | CYP1A2 (0.30) | CYP1A2 | |
| SCHEMBL29022701 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000623-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | CHAN, Hardy Wai Hong (TW) | 2026-01-01 | — | — | US | claimed |
| CN-114630651-B | Sunscreen compositions with low tack | 帝斯曼知识产权资产管理有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-112239209-B | Drug delivery via pore-modified mesoporous silica nanoparticles | 奈力生医股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| EP-3766482-B1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | NANO TARGETING & THERAPY BIOPHARMA INC (TW) | 2023-11-22 | — | — | EP | claimed |
| CN-117017812-A | Durable waterproof anti-corona mascara and preparation method thereof | 科玛化妆品(无锡)有限公司 | 2023-11-10 | — | — | CN | claimed |
| US-20230046062-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEREOF | ZEOVATION, INC. | 2023-02-16 | — | — | US | claimed |
| WO-2021113377-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2021-06-10 | — | — | WO | claimed |
| US-20210015757-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | CHAN, Hardy Wai Hong (TW) | 2021-01-21 | — | — | US | claimed |
| EP-3766482-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | Nano Targeting & Therapy Biopharma Inc. (TW) | 2021-01-20 | — | — | EP | claimed |
| CN-112239209-A | Drug delivery through pore-modified mesoporous silica nanoparticles | 奈力生医股份有限公司 | 2021-01-19 | — | — | CN | claimed |
| EP-2628744-B1 | Silicon-containing surface modifier, resist underlayer film composition containing this, and patterning process | SHINETSU CHEMICAL CO (JP) | 2016-11-30 | — | — | EP | claimed |
| EP-2628745-B1 | Silicon-containing surface modifier, resist lower layer film-forming composition containing the same, and patterning process | SHINETSU CHEMICAL CO (JP) | 2015-03-25 | — | — | EP | claimed |
| US-20130260575-A1 | SILICON PRECURSORS AND COMPOSITIONS COMPRISING SAME FOR DEPOSITING LOW DIELECTRIC CONSTANT FILMS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2013-10-03 | — | — | US | claimed |
| US-20260118767-A1 | REVERSE PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4700067-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPERSTRATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-25 | — | — | EP | disclosed |
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-12 | — | — | US | disclosed |
| US-20070238300-A1 | Silicon-containing film-forming composition, silicon-containing film, silicon-containing film-bearing substrate, and patterning method | SHIN-ETSU CHEMICAL CO., LTD. | 2007-10-11 | — | — | US | disclosed |
| US-4985135-A | Surface silylated zeolite cataysts, and processes for the preparation, and use of said catalysts in the production of high octane gasoline | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1991-01-15 | — | — | US | disclosed |
| US-4906599-A | Surface silylated zeolite catalysts, and processes for the preparation, and use of said catalysts in the production of high octane gasoline | EXXON RESEARCH & ENGINEERING CO. (US) | 1990-03-06 | — | — | US | disclosed |
| US-4454056-A | Process for the production of zeolites modified on the surface with organosilanes | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1984-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000623-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | AQP4, ABCB1, SRMS | ALDH1A1 2548/4885SHBG 1461/4885THRB 3746/4885 |
| US-20260118767-A1 | REVERSE PATTERNING PROCESS | EFNA1, EPHA4, ETV6 | ALDH1A1 4452/4885SHBG 2868/4885THRB 986/4885 |
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SMC1A, SPOUT1, LBR | ALDH1A1 1558/4885SHBG 3261/4885THRB 2064/4885 |
| US-20230046062-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEREOF | PRF1, LCT, DSTN | ALDH1A1 3756/4885SHBG 859/4885THRB 4494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.